Design and Synthesis of Potent and Selective BACE-1 Inhibitors
- 3 February 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (4) , 1458-1464
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Alzheimer's diseaseThe Lancet, 2006
- Development of BACE1 Inhibitors for Alzheimers DiseaseCurrent Medicinal Chemistry, 2006
- Inhibitors and Modulators of β- and γ-SecretaseCurrent Topics in Medicinal Chemistry, 2006
- Recent Developments of Structure Based β-Secretase Inhibitors for Alzheimers DiseaseCurrent Topics in Medicinal Chemistry, 2005
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsHuman Molecular Genetics, 2001
- Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generationNature Neuroscience, 2001
- Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProceedings of the National Academy of Sciences, 2000
- Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly stateJournal of Neuroscience, 1993
- Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's DiseaseScience, 1989